Haemophilus influenzae is an important pathogen that caused several infection diseases, such as sinusitis, otitis media, sepsis, and meningitis. This study was conducted to find out the prevalence and antimicrobial susceptibility pattern of Haemophilus influenzae isolates at general hospital in the central region of Japan from December 2015 to January 2016. Haemophilus influenzae was identified by standard laboratory procedure. Antimicrobial susceptibility testing was performed by micro dilution assay according to CLSI recommendation. One hundred ninety-one Haemophilus influenzae were isolated, among which 95 (49.7%) were from male and 96 (50.3%) were from female. The age incidence of (0) years, (≤2) years, (≤5) years, and (6≤) years groups were 22(11.5%), 92(48.2%), 61(31.9%), and 16(8.4%), respectively. Positive samples were received mostly from the nasal discharge (177/92.7%), sputum (6/3.1%), tonsillar (6/3.1%), and pharynx (2/1.0%). Ceftriaxone was the most active antibiotics with 100% susceptible rates, followed by ciprofloxacin (99.5%) and minocycline (99%) in our study. Furthermore, we categorized four patterns: beta lactamase-negative ampicillin-sensitive strain (BLNAS), beta lactamase-negative ampicillin-resistant strain (BLNAR), beta lactamase-positive ampicillin resistant strain (BLPAR), and beta lactamase-positive amoxicillin-clavulanic acid-resistant strain (BLPACR) from those ampicillin susceptible results. The numbers of female were significant greater than those of male in BLPAR (p = 0.0336). With respect to antimicrobial susceptible pattern, there was no minocycline and piperacillin resistant strain in both BLNAS and BLNAR (p < 0.0001). Haemophilus influenzae infection spreads worldwide and inadequate use of antibiotics contributes to uptake of their new antimicrobial resistance. Continuous antimicrobial surveys are need for control the emergence and spread of antimicrobial resistance to reduce the morbidity and mortality.
Introduction
Haemophilus influenzae is a Gram-negative bacterium which is isolated from the upper respiratory tract of certain normal humans. It is a major cause of bacterial meningitis in children aged under 5 years old and is also a significant agent of respiratory tract infections, including acute otitis media, sinusitis, pneumonia, and other serious invasive infections [1] . In elderly individuals, particularly those with underlying lung disease, Haemophilus influenzae can cause severe pneumonia. Of all six serotypes (a -f) of Haemophilus influenzae, serotype b caused the most invasive diseases prior to the introduction of the Haemophilus influenzae type b (Hib) vaccine [2] [3] . When the conjugate vaccine was introduced, the incidence of invasive Hib disease has been reduced significantly [4] . However, Hib immunization has yet to be included in routine childhood vaccinations in many countries, and Haemophilus influenzae remains one of the most important causes of community-acquired pneumonia [5] . In the past, ampicillin had been recommended as the drug of first choice for Haemophilus influenzae infection. However, the first ampicillin-resistant Haemophilus influenzae was reported in 1974 in several countries [6] . The major mechanism of this resistance was the production of beta-lactamases [7] . Non-beta-lactamase-mediated resistance to ampicillin in Haemophilus influenzae was first reported in the early 1980s [8] . This beta-lactamase-negative ampicillin-resistant (BLNAR) determinant was associated with the alteration of penicillin-binding proteins (PBPs) as a result of ftsI gene mutation [9] [10] . Prevalence of BLNAR among Haemophilus influenzae has been increasing in various countries in Europe and Asia [11] [12] .
The present study was conducted to find out the recent clinical characteristics of Haemophilus influenzae isolates at general hospital in the central of Japan.
Materials and Methods

Strains and Clinical Data Collection
A total of 191 Haemophilus influenzae was obtained from various clinical specimens at Daido Hospital from December 2015 to January 2016. Daido Hospital is a 404-bed private general hospital in the central region of Japan. We used medical records appended to clinical species for the analysis of clinical feature at Daido Hospital. We considered several isolates from the same region of the same patient as one isolate per one patient for the analysis in this study. All Haemophilus influenzae isolates were identified by standard conventional biochemical methods or the VITEK2 system (bioMérieux, Durham, NC, USA). Our experimental design was approved by the ethics committee at Daido hospital.
Antimicrobial Susceptibility Analysis
Haemophilus influenzae isolates were examined for seven antimicrobial susceptibilities as follows; Ampicillin (ABPC), sulbactum/Ampicillin (SBT/ABPC), Clarithromycin (CAM), Ceftriaxone (CTX), Ciprofloxacin (CPFX), Minocycline (MINO), and Piperacillin (PIPC). Minimal inhibitory concentrations (MICs) were determined at clinical laboratory in Daido Hospital using broth micro dilution methodology with the VITEK2 system. Evaluation of susceptibilities was calculated based on Clinical Laboratory Standard Institute (CLSI) break point [13] . We defined the ampicillin-resistant Haemophilus influenzae as follows; beta lactamase-negative ampicil- 
Statistical Analysis of the Data
We conducted the statistical analysis with the chi-squared test or Fisher's exact test when appropriate. Differences were considered significant when p was <0.05.
Results
First of all, we screened the ampicillin susceptibility of all Haemophilus influenzae isolates. From those ampicillin susceptible results, we categorized four patterns: BLNAS, BLNAR, BLPAR, and BLPACR ( Table 1) . Next, we compared the differences of clinical characteristics and antimicrobial susceptible pattern except ampicillin among ampicillin-resistant Haemophilus influenzae in this study. One hundred ninety-one Haemophilus influenzae were isolated among which 95(55.6%) were from male and 96(44.4%) were from female ( Table 1) . According to ampicillin susceptibility, the numbers of female were significant greater than those of male in BLPAR (p = 0.0336). The age incidence among 0 years age group was 22 (11.5%), ≤2 years age group, 92(48.2%), ≤5 years age group, 61(31.9%), and 6≤ years it was 16(8.4%) ( Table 1) . According to ampicillin susceptibility, there was no significant difference in age group. Most of the Haemophilus influenzae isolates were from nasal discharge (177/92.7%), followed by sputum (6/3.1%), tonsillar (6/3.1%) and pharynx (2/1.0%) ( Table 1) . According to ampicillin susceptibility, there was no significant difference in specimen group.
The results of antimicrobial susceptible patterns of Haemophilus influenzae isolates to various antibiotics tested in this study were shown in Table 2 . Ceftriaxone was the most active antibiotics with 100% susceptible rates, followed by ciprofloxacin (99.5%) and minocycline (99%). According to ampicillin susceptibility, there was no minocycline and piperacillin resistant strain in both BLNAS and BLNAR.
Discussion
In this study, we described the characteristics of Haemophilus influenzae isolates from July 2014 to June 2015 at general hospital in the central region of Japan. With respect to gender group, our study showed the male to female ratio was about 0.99 and there were no significant differences among gender. We clarified Haemophilus influenzae with age distribution. The present study reveals the about half of Haemophilus influenzae were isolated from under 2 years age patients. In the analysis of specimen's type, we found that specimens where most patients with Haemophilus influenzae were detected were nasal discharge. In the analysis of antimicrobial susceptibility, we did not find any ceftriaxone-resistant Haemophilus influenzae in our study. Furthermore, in our study, ciprofloxacin, minocycline, and piperacillin were also effective antibacterial agent against Haemophilus influenzae, especially BLNAS and BLNAR. However, about 23% of Hemophilus influenzae were non-susceptible to clarithromycin. As ampicillin-resistant Haemophilus influenzae spreads widely, several investigators reported antimicrobial susceptible patterns of Haemophilus influenzae in Asian country. In Japan, the prevalence of BLNAR was 63.5% and the rate of BLPAR also ranged from 6.4% to 8.7% from acute otitis media patient [15] . Another Japanese report from acute otitis media patients showed that the rate of BLNAR and BLPAR were 60.5% and 8.3% [16] . Furthermore, the prevalence of BLNAR, BLPAR, and BLPACR were 62.4, 6.1, and 4.1% in other Japanese study [17] . The rate of levofloxacin-resistant was 24.3% in another Japanese report [18] . In South Korea, the rate of BLNAR, BLPAR, and BLPACR were 40.2, 9, and 24.6 [19] .
In China, the rate of beta-lactamase positive was 35.8% [20] . In another Chinese report, the rate of beta-lactamase positive was 61% and the rate of tetracycline resistant was 94.5% [21] . In Thailand, the rate of ampicillin resistant, tetracycline resistant, clarithromycin resistant, and ciprofloxacin resistant bacteria were 50, 31.9, 5.7, and 0%, respectively [22] . In Turkey, the rate of ampicillin/clavulanic acid resistant, tetracycline resistant, clarithromycin resistant, and ciprofloxacin resistant bacteria were 0, 15, 4, and 0%, respectively [23] . In our case, the prevalence of BLNAR, BLPAR, and BLPACR were 19.9, 7.3, and 40.3% and the rate of beta-lactamase positive was 47.6%. Our results are similar to the result in South Korea, not in Japan. For the other antibioticresistance except ampicillin, our result showed that the CPFX-, MINO, and CAM-resistant were 0.5, 1, and 8.4%. The antibiotic resistant rates in our studies were relatively low compared to other country. Although Haemophilus influenzae spreads widely, the susceptibility patterns of Haemophilus influenzae in Asia have diversified by region [24] . Further analysis is needed for the clarification of epidemiology of Haemophilus influenzae in Asian countries.
Conclusion
Incidence of Haemophilus influenzae infection is increasing worldwide and may lead to severe invasive infection. Our investigation aims to guide medical staffs on appropriate use of antibiotics. Furthermore, our aim is not only to reduce the morbidity and mortality in the patients but also to control the emergence and spread of antimicrobial resistance among Haemophilus influenzae. Our results strongly emphasize the need for continuous epidemiological monitoring of antibiotic resistant Haemophilus influenzae.
